Blog hero background graphic

Blog

Initial CGT launches faltered. The next wave doesn’t have to.

Four key considerations for commercializing the next wave of potentially curative therapies from Beghou Partner, Robert Rouse. High costs,...

Initial CGT launches faltered. The next wave doesn’t have to.featured image

What agentic AI unlocks for pharma teams

Beghou adds new Partners to strengthen market access, cell & gene therapy, and technology capabilities

Beghou expands global footprint with new Bengaluru office

Beghou prepares for next phase of growth, names Adrienne Lovink, Chief Services Officer, to succeed Beth Beghou, Founder and CEO

Beghou names award-winning artificial intelligence executive, thought leader, and inventor as new VP, AI Innovation

Get your data ready for AI

Navigating the healthcare data swamp: 4 steps to a scalable data ecosystem

GenAI implementation in life sciences: Strategies to ensure adoption

AI for medical field notes

Emerging biopharma data and analytics roadmap: A guide to setting up your data and analytics foundation for launch

3 steps to successfully designing and implementing the technology for a med affairs AI solution

Pre-launch prep for emerging biopharmas: Data first, then the rest

Which goals, skills, and technology do you need to kick off your generative AI roadmap?

Delivering personalized experiences at scale: A fresh look at customer centricity

How to accelerate and maximize technology and data investments in 2025